ARCHIVES

NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future

This article is from The Cancer Letter archive.

Vol. 16 No. 37 | September 28, 1990

Download PDF Visit The Full Archive

Related Articles

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

NIH Funding Opportunities Listed

March 13, 2009

Osteoporosis Treatments Associated With Decreased Risk Of Breast Cancer

March 26, 2010

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002